Tumour necrosis factor-α inhibitors are glucocorticoid-sparing in rheumatoid arthritis

Research output: Contribution to journalJournal articleResearchpeer-review

Abstract

Rheumatoid arthritis (RA) is a chronic disease with autoimmune traits of unknown aetiology which primarily affects synovial joints. Glucocorticoids (GCs) are still widely used in RA treatment despite the expanding use of targeted and very efficient agents. The objective of this study was to assess the impact of treatment with tumour necrosis factor-α inhibitors (TNFi) on GC utilization in real-life practice among Danish RA patients.
Original languageEnglish
JournalDanish Medical Bulletin (Online)
Volume58
Issue number4
Pages (from-to)A4257
ISSN1603-9629
Publication statusPublished - 2011

Fingerprint

Glucocorticoids
Tumor Necrosis Factor-alpha
Joints

Cite this

@article{3452be37f6474c428df3fb54bc2937d0,
title = "Tumour necrosis factor-α inhibitors are glucocorticoid-sparing in rheumatoid arthritis",
abstract = "Rheumatoid arthritis (RA) is a chronic disease with autoimmune traits of unknown aetiology which primarily affects synovial joints. Glucocorticoids (GCs) are still widely used in RA treatment despite the expanding use of targeted and very efficient agents. The objective of this study was to assess the impact of treatment with tumour necrosis factor-α inhibitors (TNFi) on GC utilization in real-life practice among Danish RA patients.",
author = "Nilsson, {Anna Christine} and Christensen, {Anne Friesgaard} and Peter Junker and Lindegaard, {Hanne Merete}",
year = "2011",
language = "English",
volume = "58",
pages = "A4257",
journal = "Danish Medical Journal",
issn = "1603-9629",
publisher = "DANISH MEDICAL ASSOC",
number = "4",

}

Tumour necrosis factor-α inhibitors are glucocorticoid-sparing in rheumatoid arthritis. / Nilsson, Anna Christine; Christensen, Anne Friesgaard; Junker, Peter; Lindegaard, Hanne Merete.

In: Danish Medical Bulletin (Online), Vol. 58, No. 4, 2011, p. A4257.

Research output: Contribution to journalJournal articleResearchpeer-review

TY - JOUR

T1 - Tumour necrosis factor-α inhibitors are glucocorticoid-sparing in rheumatoid arthritis

AU - Nilsson, Anna Christine

AU - Christensen, Anne Friesgaard

AU - Junker, Peter

AU - Lindegaard, Hanne Merete

PY - 2011

Y1 - 2011

N2 - Rheumatoid arthritis (RA) is a chronic disease with autoimmune traits of unknown aetiology which primarily affects synovial joints. Glucocorticoids (GCs) are still widely used in RA treatment despite the expanding use of targeted and very efficient agents. The objective of this study was to assess the impact of treatment with tumour necrosis factor-α inhibitors (TNFi) on GC utilization in real-life practice among Danish RA patients.

AB - Rheumatoid arthritis (RA) is a chronic disease with autoimmune traits of unknown aetiology which primarily affects synovial joints. Glucocorticoids (GCs) are still widely used in RA treatment despite the expanding use of targeted and very efficient agents. The objective of this study was to assess the impact of treatment with tumour necrosis factor-α inhibitors (TNFi) on GC utilization in real-life practice among Danish RA patients.

M3 - Journal article

C2 - 21466765

VL - 58

SP - A4257

JO - Danish Medical Journal

JF - Danish Medical Journal

SN - 1603-9629

IS - 4

ER -